Dror Bashan Protalix Bio Therapeutics, Inc. (PLX) insider trading activity
Dror Bashan is PRESIDENT AND CEO of Protalix BioTherapeutics, Inc.. Currently has a direct ownership of 132,516 shares of PLX, which is worth approximately $162,994. The most recent transaction as insider was on Oct 19, 2023, when has been sold 64,516 shares (Common Stock) at a price of $1.41 per share, resulting in proceeds of $90,967. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
133K
0%
3M change
0%
12M change
Total Value Held
$162,994
Dror Bashan Transaction History
DB
Dror Bashan
PRESIDENT AND CEO
Carmiel, L3